Purchase Agreements
All Business Industries
Ultragenyx Pharmaceutical Inc. (143) | Purchase Agreements (3)
- Royalty Purchase Agreement by and among Rare Delaware Inc., Ultragenyx Pharmaceutical Inc. and OCM LS23 Holdings LP dated as of July 14, 2022 (Filed With SEC on July 29, 2022)
- Equity Purchase Agreement, dated as of June 18, 2019 by and among Ultragenyx Pharmaceutical Inc. and Arcturus Therapeutics Ltd (Filed With SEC on July 31, 2020)
- Royalty Purchase Agreement, dated as of December 17, 2019, between Ultragenyx Pharmaceutical Inc. and RPI Finance Trust (Filed With SEC on February 14, 2020)